Skip to main content
This content is available to subscribers. Subscribe now. Already have an account? Sign in.

Dengue Suppression by Male Wolbachia-Infected Mosquitoes

Authors: Jue Tao Lim, Ph.D. https://orcid.org/0000-0002-2245-0331, Chee-Seng Chong, Ph.D., Chia-Chen Chang, Ph.D., Diyar Mailepessov, M.P.H., Borame Dickens, Ph.D., Yee Ling Lai, B.Sc., Lu Deng, B.Sc., +13 , Caleb Lee, M.Sc., Li Yun Tan, B.Sc., Grace Chain, B.Sc., Muhammad Faizal Zulkifli, B.Eng., Jonathan Wee Kent Liew, Ph.D., Kathryn Vasquez, M.Sc., Man Ling Chau, M.P.H., Youming Ng, B.Sc., Vernon Lee, Ph.D., Judith Chui Ching Wong, Ph.D., Shuzhen Sim, Ph.D., Cheong Huat Tan, Ph.D., and Lee Ching Ng, Ph.D., for the Project Wolbachia–Singapore Consortium*Author Info & Affiliations
Published February 11, 2026
DOI: 10.1056/NEJMoa2503304

Abstract

Background

Wild-type female Aedes aegypti mosquitoes that mate with male A. aegypti mosquitoes that have been infected with the wAlbB strain of Wolbachia pipientis bacteria produce nonviable offspring owing to cytoplasmic incompatibility. Repeated releases of wolbachia-infected males can potentially suppress wild-type mosquito populations and reduce the risk of dengue virus infection.

Methods

We conducted a trial involving the release of male A. aegypti mosquitoes infected with the wAlbB strain of wolbachia bacteria for the control of dengue in Singapore, a tropical city-state. In this cluster-randomized trial with test-negative controls, we divided 15 geographic population clusters into two groups: 8 clusters received deployments of male wolbachia-infected mosquitoes (intervention clusters) and 7 clusters received no deployments (control clusters). The primary end point was the diagnosis of symptomatic dengue virus infection of any severity caused by any serotype of the virus, as measured by the odds ratio for the distribution of wolbachia exposure among laboratory-confirmed reported dengue cases as compared with test-negative controls.

Results

A total of 393,236 residents lived in the intervention clusters, and 331,192 lived in the control clusters. Adult wild-type A. aegypti populations were suppressed across the intervention clusters. The baseline average abundance of the mosquitoes (number of adult female mosquitoes trapped divided by number of traps) was 0.18 and 0.19 in the intervention and control clusters, respectively; from 3 months after the initiation of the intervention until the end of the 24-month trial period, the average abundance was 0.041 and 0.277, respectively. In the intention-to-treat analysis at 6 months or more, the percentage of residents in the intervention clusters who were dengue-positive was lower than that in the control clusters (354 of 5722 tests [6%] vs. 1519 of 7080 tests [21%]). The protective efficacy of the intervention, calculated as (1−odds ratio)×100, ranged from 71 to 72% with 3 to 12 months or more of wolbachia mosquito exposure, as represented by odds ratios of 0.28 to 0.29.

Conclusions

Release of sterile wolbachia-infected male A. aegypti mosquitoes reduced vector populations and the risk of dengue infection in Singapore. (Funded by the Singapore Ministry of Finance and others; ClinicalTrials.gov number, NCT05505682.)

Access this content

Select an option below:

Create your account for free access to subscriber-only content.

Get Free Access Now Subscribe For Full Access

Already have an account?
Sign In

Print subscriber?
Activate your online access

Interested in purchasing this article?
BUY NOW FOR $55

Are you a member of an institution such as a university or hospital?Learn more about Institutional Access

Notes

This article was published on February 11, 2026, at NEJM.org.
A data sharing statement provided by the authors is available with the full text of this article at NEJM.org.
Supported by the Singapore Ministry of Finance, the Ministry of Sustainability and the Environment, the National Environment Agency, and the National Robotics Program; and by a start-up grant (to Jue Tao Lim) from the Ministry of Education.
Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
We thank the members of the Dengue Expert Advisory Panel of the National Environment Agency (Tim Barkham, Christl Donnelly, Neil Ferguson, Duane Gubler, Ary Hoffmann, and Chia Kee Seng) for their advice on the trial design and analysis; Zhiyong Xi (of Michigan State University) for providing the mosquitoes infected with the AlbB strain of wolbachia bacteria, which was used to generate the AlbB-SG line essential to this trial; and the members of the Production, Release, Partnerships, and Program Management teams of the Environmental Health Institute for their technical and program support.

Supplementary Material

Protocol (nejmoa2503304_protocol.pdf)
Supplementary Appendix (nejmoa2503304_appendix.pdf)
Disclosure Forms (nejmoa2503304_disclosures.pdf)
Data Sharing Statement (nejmoa2503304_data-sharing.pdf)

Create your account for free access to subscriber-only content.Get Free Access Now.